Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

PAHC

BUY

Phibro Animal Health Corporation · Healthcare · United States · $1.4B · Avg Vol: $10M/d

76
StockRank
Get insider-trade alerts
Q
64
V
60
M
46
P/E (TTM)
14.3x
ROE
30.3%
D/E
2.2x
Dividend %
1.4%
Dir. Trades · 180d
+$317.7K · −$4.6M →
Buybacks · 180d
None →

COMPANY DESCRIPTION

Phibro Animal Health Corporation is a U.S.-based company developing, manufacturing, and marketing a diverse portfolio of animal health and nutrition products, including medicated feed additives, vaccines, and nutritional supplements. The company's competitive moat is built on its extensive industry experience, strong relationships with livestock producers, and a broad product offering vital for animal productivity and disease prevention. This integrated approach solidifies its position in the global animal health market.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue942.3M977.9M1.0B1.3B11.2%1.5B1.5B1.5B9.3%
EPS1.210.810.061.19-0.6%2.311.751.9026.5%
Shares40.5M40.5M40.5M40.5M+0.1%————
Debt470.5M510.0M525.5M761.6M17.4%788.7M———
Equity262.4M282.5M256.6M285.7M2.9%————
Op CF31.6M13.3M87.6M80.1M36.3%66.1M———
Inv CF-22.6M-74.0M-48.2M-288.7M—————
Fin CF16.3M27.0M-6.8M207.1M—————
Loading 1Y...
PRICE (1Y)+11.8%
30.5331.7132.8934.0635.24Jun 12Jul 7Jul 27
SMA 50SMA 200
Close
$35.24
RSI (14)
64.6
52W High
$59.83
From 52W High
0.6%

SCORE BREAKDOWN

Quality
64
ROIC
9.5%72.5
ROE
30.3%94.0
GP/Assets
35.9%76.0
Op. Margin
12.6%71.5
FCF/Assets
3.1%60.5
Piotroski
668.3
Int. Cover
3.0x46.3
D/E Ratio
2.18x5.3
Current Ratio
3.17x56.2
Value
60
P/E (TTM)
14.3x76.1
EV/EBITDA
8.7x74.4
P/FCF
33.0x40.6
P/B
3.7x36.5
P/S
0.9x85.5
Div Yield
1.4%36.1
Momentum
46
52W High %
59%38.1
RS 6M
-17%50.3
SMA 50/200
0.77x15.3
EPS Rev 4W
0.0%62.6
EPS Rev 12W
-1.3%44.0
EPS Improve
+45%52.1
Q Growth
15%56.5

FUNDAMENTALS

Market Cap
$1.4B
P/E (Forward)
9.9x
Gross Margin
32.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PAHC are excluded.

TickerCompanyMkt CapStockRankSignal
PAHCPhibro Animal Health Corporation(you)$1.4B76BUY
AMPHAmphastar Pharmaceuticals, Inc.$825M75BUY
TRLVTrulieve Cannabis Corp.$1.6B87STRONG BUY
PBHPrestige Consumer Healthcare Inc.$2.4B82STRONG BUY
ETONEton Pharmaceuticals, Inc.$1.2B62HOLD
XERSXeris Biopharma Holdings, Inc.$1.4B58HOLD
GTII.CNGreen Thumb Industries Inc.$1.6B93STRONG BUY
COLLCollegium Pharmaceutical, Inc.$1.1B95STRONG BUY
BCRXBioCryst Pharmaceuticals, Inc.$2.4B88STRONG BUY
PCRXPacira BioSciences, Inc.$1.0B93STRONG BUY

Peer medians: ROE -25.6% · P/E 27.7x · Gross margin 50.6%

Phibro Animal Health Corporation (PAHC) — Stock Score Summary

Phibro Animal Health Corporation (PAHC) has a MoatMap StockRank of 76/100 based on Quality (64/100), Value (60/100), and Momentum (46/100) factor scores. The current signal is BUY.

Phibro Animal Health Corporation is a U.S.-based company developing, manufacturing, and marketing a diverse portfolio of animal health and nutrition products, including medicated feed additives, vaccines, and nutritional supplements. The company's competitive moat is built on its extensive industry experience, strong relationships with livestock producers, and a broad product offering vital for animal productivity and disease prevention. This integrated approach solidifies its position in the global animal health market.

Key Financial Metrics

Price$35.24
Market Cap$1.4B
P/E (TTM)14.31
P/E (Forward)9.88
Price/Book3.71
Return on Equity30.3%
Return on Invested Capital9.5%
Debt/Equity2.18x
Gross Margin32.6%
Operating Margin12.6%
Revenue Growth10.3%
Dividend Yield1.4%
Free Cash Flow$42M

Phibro Animal Health Corporation operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Phibro Animal Health Corporation’s (PAHC) StockRank?
MoatMap’s StockRank for Phibro Animal Health Corporation (PAHC) is 76/100, with a Buy signal. It is a composite of Quality (64), Value (60), and Momentum (46) factor ranks across MoatMap’s 20,000+ stock universe.
Does Phibro Animal Health Corporation have an economic moat?
Phibro Animal Health Corporation (PAHC) has a Quality factor score of 64/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Phibro Animal Health Corporation a buy, hold, or sell?
MoatMap’s current signal for Phibro Animal Health Corporation (PAHC) is Buy, based on a StockRank of 76/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Phibro Animal Health Corporation in?
Phibro Animal Health Corporation (PAHC) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksPAHC deep dive reportAI ChampionsHow we score stocksSense-check another stock